Youngwoo Jeon

Yeouido St. Mary's Hospital
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Outcomes of tisagenlecleucel versus allogeneic hematopoietic stem cell transplantation in relapsed or refractory large B-cell lymphoma.

Outcomes of tisagenlecleucel versus allogeneic hematopoietic stem cell transplantation in relapsed or refractory large B-cell lymphoma.

Journal: Cytotherapy
Published: September 25, 2025

Impact of KMT2A Rearrangement on Peripheral T-Cell Lymphoma, Not Otherwise Specified, and Angioimmunoblastic T-Cell Lymphoma.

Impact of KMT2A Rearrangement on Peripheral T-Cell Lymphoma, Not Otherwise Specified, and Angioimmunoblastic T-Cell Lymphoma.

Journal: Biomedicines
Published: September 04, 2025

Survival Machine Learning Methods Improve Prediction of Histologic Transformation in Follicular and Marginal Zone Lymphomas.

Survival Machine Learning Methods Improve Prediction of Histologic Transformation in Follicular and Marginal Zone Lymphomas.

Journal: Cancers
Published: August 11, 2025

Comprehensive analysis of mortality risk factors in low-grade B-cell lymphoma.

Comprehensive analysis of mortality risk factors in low-grade B-cell lymphoma.

Journal: PloS one
Published: August 04, 2025

Prognostic factors and outcomes of tisagenlecleucel in relapsed or refractory B-cell malignancies: a single-center real-world study.

Prognostic factors and outcomes of tisagenlecleucel in relapsed or refractory B-cell malignancies: a single-center real-world study.

Journal: Cytotherapy
Published: July 14, 2025

Risk Factors Influencing Survival in T-Cell Lymphoblastic Lymphoma and T-Cell Acute Lymphoblastic Leukemia.

Risk Factors Influencing Survival in T-Cell Lymphoblastic Lymphoma and T-Cell Acute Lymphoblastic Leukemia.

Journal: Cancer medicine
Published: July 09, 2025

Dual targeting of EZH2 and PD-L1 in Burkitt's lymphoma enhances immune activation and induces apoptotic pathway.

Dual targeting of EZH2 and PD-L1 in Burkitt's lymphoma enhances immune activation and induces apoptotic pathway.

Journal: Frontiers in immunology
Published: February 18, 2025

Case Report: A case series on histiocytic sarcoma - various clinical features and patient outcomes.

Case Report: A case series on histiocytic sarcoma - various clinical features and patient outcomes.

Journal: Frontiers in oncology
Published: October 03, 2024

DL-ICE as a bridge to allogeneic transplantation in relapsed/refractory PTCL: survival outcomes and prognostic factors.

DL-ICE as a bridge to allogeneic transplantation in relapsed/refractory PTCL: survival outcomes and prognostic factors.

Journal: Frontiers in oncology
Published: July 08, 2024

Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma.

Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma.

Journal: Frontiers in oncology
Published: February 20, 2024

Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data.

Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data.

Journal: Frontiers in oncology
Published: December 28, 2023

Identifying and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing.

Identifying and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing.

Journal: The Korean journal of internal medicine
Published: October 15, 2023
Showing 1-12 of 21

Last Updated: 09/26/2026